Good post fx. That is why I am here. Greetings from StLouis Missouri!
It seems odd to me that when speaking of a possible buyout of Fum as a company that the value of the DermaSys system is never mentioned. Is it really something special? I suspect it must be or why would T&R bother to bring out another TPR gel in a market that is loaded with them now? Could it not be used to deliver other drugs? Seems like a formidable asset unless I am missing something.
Sorry for the glitch there more to the post but tough to do this with the cell phone.
I have been following FUM for more than a year and finally bought shares in mid June. I have to say I have enjoyed reading all of you guy's posts going back to '16.
I have been following FUM for more than a year and finally bought shares in mid June. I have to say I have enjoyed reading all of you guy's posts going back to '16
Big pharmas have an extensive pipeline of drugs but none that are this much fun. I think if Med ever makes it to market the amount of recreational use by men with little or no ED issues will be massive. And if it eventually went OTC, even more so. What is not to like about an enhanced experience as reported in ph 2 trials? Everyone surely seemed to enjoy the stuff even at the low dose..